PLSE

Conviction 83HealthcareScan · Mon, Aug 10, 2026

PLSE$41.53-2.07%

ResistanceSupportVol 14Insider buy

Vol MA14 461.14K

May 11May 28Jun 16Jul 6Jul 23Aug 10

PULSE BIOSCIENCES, INC.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.pulsebiosciences.com ↗

Price41.53

Change-2.07%

Gap+1.70%

Rel volume1.13×

Avg volume396.14K

Avg $ vol13.63M

SMA 2033.49

SMA 5029.25

SMA 20021.01

Price vs 50+42.01%

Price vs 200+97.65%

MA stackbullish

50/200 cross—

Supertrendup · 33.58

RSI (14)75

MACD hist0.78

MACD cross—

Stoch %K / %D73 / 82

ADX (14)56

+DI / −DI42 / 7

RSI divergence—

MACD divergence—

ATR %+6.49%

ADR %7.97%

52w high42.41

52w low12.66

From 52w high-2.07%

Above 52w low+228.04%

New 52w highNo

SqueezeOff

Bollinger width57.34%

%B0.92

Donchian pos79.15%

Donchian high45.90

Donchian low24.94

AVWAP (52w high)41.96

vs AVWAP high-1.01%

AVWAP (52w low)23.19

vs AVWAP low+79.12%

OBV trendUp

Chaikin MF (20)0.18

Today vs 20d1.13×

Avg vol (14d)461.14K

Avg vol (20d)396.14K

Avg $ vol (20d)13.63M

Market cap2.96B

RS 3m (vs SPY)+110.79%

RS 6m (vs SPY)+195.67%

RS line new highYes

Trend template8/8

Technical rank96.2

1 week+10.07%

1 month+57.97%

3 months+117.66%

6 months+100.14%

1 year+182.13%

YTD+210.16%

P/E-40.70

P/B29.77

P/S—

P/FCF-54.41

EPS-1.08

Div yield—

ROE-73.15%

ROA-62.98%

Debt/Eq—

Current9.63

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-35.82%

Price target41.00

Target upside-1.28%

Analyst ratingBuy

Institutional12.85%

Ent. value2.86B

Revenue434K

Net income-24.66M

Gross profit—

Free cash flow-54.44M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out69.21M

Employees116

ListedWed, May 18, 2016

Free float18.17M

Float %26.6%

Short interest2.89M

Days to cover11.6d

Short volume47.5%

Squeeze score64 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.36 vs −$0.31

Last surprise-16.1% miss

Setup gradeA

Conviction83 / 100

Pattern quality—

Tech rank96.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance35.33

Support27.23

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PLSE

All disclosures →

No recent disclosed trades by Congress in PLSE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PLSE · 4 buys

Insider	Side	Shares	Value	Traded	Filed
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Buy	660.23K	$13M	2026-05-11	2026-05-15
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Other	—	—	2026-05-11	2026-05-15
LAVIOLETTE PAUL A Chief Executive Officer · Common Stock · 2026-05-11	Buy	15K	$295K	2026-05-11	2026-05-11
LAVIOLETTE PAUL A Chief Executive Officer · Common Stock · 2026-05-11	Buy	15K	$295K	2026-05-11	2026-05-11
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Other	—	—	2026-05-11	2026-05-11
DUGGAN ROBERT W Director · Common Stock · 2026-05-11	Buy	660.23K	$13M	2026-05-11	2026-05-11

SEC filings

EDGAR filings in PLSE · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.